Antimetastatic Effect of Fucoidan-Sargassum against Liver Cancer Cell Invadopodia Formation via Targeting Integrin αVβ3
Anti-metastatic effect via targeting Integrin αVβ3 and mediating αVβ3/Src/E2F1 signaling.
Anti-metastatic effect via targeting Integrin αVβ3 and mediating αVβ3/Src/E2F1 signaling.
Synergy with sorafenib to overcome resistance in liver cancer.
First completed randomized, double-blind, placebo-controlled trial in HCC, comparing oligo-fucoidan alongside standard care.
Induction of apoptosis and inhibition of proliferation via MAPK/ERK and PI3K/Akt pathways.